Kaylee E Caniff (Kaylee Caniff)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Multidrug Resistant

Acinetobacter Baumannii

Systematic Review

Top Venues

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Amer El Ghali, Ashlan J Kunz Coyne, Kaylee E Caniff, Callan Bleick, Michael Joseph Rybak
Sulbactam-durlobactam: A Novel β-lactam-β-lactamase Inhibitor Combination Targeting Carbapenem-Resistant Acinetobacter baumannii Infections. Pharmacotherapy (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy (2023)
Ashlan J Kunz Coyne, Shelbye Herbin, Kaylee E Caniff, Michael Joseph Rybak
Steno-sphere: Navigating the Enigmatic World of Emerging Multidrug-Resistant Stenotrophomonas maltophilia. Pharmacotherapy (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)
Kaylee E Caniff, Nicholas Rebold, Michael Joseph Rybak
Oral stepdown in Gram-positive bloodstream infections: A step in the right direction. Pharmacotherapy 43 (3) (2023)